{"id":"zanamivir-for-inhalation","safety":{"commonSideEffects":[{"rate":"1-2","effect":"Bronchospasm"},{"rate":"10-15","effect":"Cough"},{"rate":"5-10","effect":"Throat discomfort"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Nasal symptoms"}]},"_chembl":{"chemblId":"CHEMBL414779","moleculeType":"Small molecule","molecularWeight":"2080.15"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Zanamivir is a sialic acid analog that binds to and inhibits influenza neuraminidase, the viral enzyme responsible for cleaving sialic acid receptors on host cell surfaces. By blocking neuraminidase activity, the drug prevents newly synthesized viral particles from being released from infected cells, thereby reducing viral spread and limiting infection progression. The inhalation formulation delivers the drug directly to the respiratory tract where influenza infection occurs.","oneSentence":"Zanamivir inhibits neuraminidase, an enzyme on the surface of influenza viruses, preventing viral release from infected cells and blocking spread of infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:16:28.163Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of acute uncomplicated influenza A and B infection in patients 7 years and older"},{"name":"Prophylaxis of influenza A and B in patients 5 years and older"}]},"trialDetails":[{"nctId":"NCT05648448","phase":"PHASE2","title":"A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2023-02-22","conditions":"Influenza, Influenza, Human","enrollment":3000},{"nctId":"NCT01462487","phase":"","title":"Safety of Inhaled Zanamivir in Pregnancy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-07","conditions":"Influenza, Human","enrollment":1},{"nctId":"NCT01459081","phase":"PHASE3","title":"Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China","status":"COMPLETED","sponsor":"Jiangsu Simcere Pharmaceutical Co., Ltd.","startDate":"2011-10","conditions":"Influenza A Virus Infection, Influenza B Virus Infection","enrollment":298},{"nctId":"NCT00830323","phase":"PHASE2","title":"Efficacy and Safety of Combination Therapies With Oseltamivir & Zanamivir or Oseltamivir & Amantadine Versus Oseltamivir Monotherapy in the Treatment of Seasonal Influenza A Infection","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2009-01","conditions":"Influenza A Infection","enrollment":60},{"nctId":"NCT00980109","phase":"PHASE4","title":"Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2009-09","conditions":"Influenza","enrollment":390}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Rotadisk/Diskhaler"],"phase":"marketed","status":"active","brandName":"zanamivir for inhalation","genericName":"zanamivir for inhalation","companyName":"University of Oxford","companyId":"university-of-oxford","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Zanamivir inhibits neuraminidase, an enzyme on the surface of influenza viruses, preventing viral release from infected cells and blocking spread of infection. Used for Treatment of acute uncomplicated influenza A and B infection in patients 7 years and older, Prophylaxis of influenza A and B in patients 5 years and older.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}